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Background. Syphilis is re-emerging globally in general and HIV-infected populations, and repeated syphilis episodes may play 
a central role in syphilis transmission among core groups. Besides sexual behavioral factors, little is known about determinants of 
repeated syphilis episodes in HIV-infected individuals—including the potential impact of preceding syphilis episodes on subsequent 
syphilis risk.
Methods. In the prospective Swiss HIV cohort study, with routine syphilis testing since 2004, we analyzed HIV-infected men 
who have sex with men (MSM). Our primary outcome was first and repeated syphilis episodes. We used univariable and multivariable 
Andersen-Gill models to evaluate risk factors for first and repeated incident syphilis episodes.
Results. Within the 14-year observation period, we included 2513 HIV-infected MSM with an initially negative syphilis test. 
In the univariable and multivariable analysis, the number of prior syphilis episodes (adjusted hazard ratio [aHR] per 1-episode 
increase, 1.15; 95% confidence interval [CI], 1.01–1.31), having occasional sexual partners with or without condomless anal sex 
(aHR, 4.99; 95% CI, 4.08–6.11; and aHR, 2.54; 95% CI, 2.10–3.07), and being currently on antiretroviral therapy (aHR, 1.62; 95% CI, 
1.21–2.16) were associated with incident syphilis.
Conclusions. In HIV-infected MSM, we observed no indication of decreased syphilis risk with repeated syphilis episodes. The 
extent of sexual risk behavior over time was the strongest risk factor for repeated syphilis episodes. The observed association of anti-
retroviral therapy with repeated syphilis episodes warrants further immunological and epidemiological investigation.
Keywords.  HIV; immunity; repeated infection; risk factor; syphilis.
Syphilis is re-emerging globally in general and HIV-infected 
populations as a major threat to individual and public health 
[1, 2]. Syphilis can be easily transmitted—often in asympto-
matic stages—and may lead to independent syphilis outbreaks 
and sustained epidemics [1, 3]. Repeated syphilis episodes may 
play a central role in syphilis transmission dynamics among 
so-called core groups and high-volume repeaters [4, 5]; how-
ever, besides sexual behavioral aspects, little is known about 
risk factors for repeated syphilis episodes in HIV-infected in-
dividuals. It has been speculated that repeated syphilis episodes 
induce or boost a host immune reaction, which may ultimately 
decrease the likelihood of acquiring further syphilis episodes 
[1, 6]. In HIV-infected populations, however, epidemiological 
data on the potential impact of syphilis immunity and other 
factors such as antiretroviral therapy (ART) on the occurrence 
of repeated syphilis episodes are scarce [7]. This information 
may help to improve targeted syphilis prevention strategies for 
high-risk individuals and to guide current syphilis vaccine de-
velopments [8].
In HIV-infected men who have sex with men (MSM), we 
aimed to identify risk factors for incident syphilis and in par-
ticular for repeated syphilis episodes. We especially wanted to 
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assess whether syphilis risk is associated with the number of 
preceding syphilis episodes.
METHODS
Swiss HIV Cohort Study
The Swiss HIV Cohort Study (SHCS; www.shcs.ch) is a nation-
wide, prospective multicenter cohort study with semi-annual 
visits and blood collections—having enrolled >20 000 HIV-
infected adults living in Switzerland since 1988 [9]. The SHCS 
is representative of the HIV epidemic in Switzerland and covers 
around 80% of new HIV infections in Switzerland since 1996 [9, 
10]. The data collection is coded, and a written informed con-
sent is required before study inclusion. In the SHCS, a stand-
ardized protocol is used for data collection. Sociodemographic, 
behavioral, and clinical data are recorded at study entry, and 
several laboratory tests are routinely performed at registration 
[9]. Clinical, treatment, and laboratory information (eg, cluster 
of differentiation 4 [CD4] cell counts, HIV viral load) are re-
corded twice per year during follow-up visits. Behavioral in-
formation, such as condom use, type of partners (occasional 
and/or stable), alcohol use, and drug use in the last 6 months 
are self-reported during follow-up visits. Additional interim 
laboratory evaluations are recorded, if available.
The SHCS is registered on the Swiss National Science 
Foundation longitudinal platform (www.snf.ch/en/funding/
programmes/longitudinal-studies) and is accepted by the 
responsible ethical committees in Switzerland (www.shcs.
ch/206-ethic-committee-approval-and-informed-consent).
Participants
We restricted our study population within the SHCS to MSM, 
who account for >80% of syphilis episodes and are dispropor-
tionally burdened by syphilis [2, 11, 12]. We included MSM 
who had their first nontreponemal and treponemal syphilis 
test—with a negative result—performed after January 1, 2004, 
and who had at least 2 consecutive syphilis tests recorded in 
the database. The observation period ended on January 1, 2018.
Syphilis Testing and Outcome Measures
Syphilis testing in the SHCS includes both concur-
rent nontreponemal and treponemal assays [10, 11]: The 
nontreponemal assay comprises either the Veneral Diseases 
Research Laboratory (VDRL) test or the rapid plasma reagin 
(RPR) test; the treponemal assay involves a Treponema pallidum 
particle agglutination/Treponema pallidum hemagglutination 
(TPPA/TPHA), Liaison (CLIA), Architect (CMIA) test, or a 
IgG/IgM immunoassay (Elecsys Syphilis immunoassay). Since 
the restart of routine syphilis testing in the SHCS in 2004, MSM 
have been tested for syphilis annually, whereas other individuals 
are tested for syphilis once every 2 years. Additionally, individual 
syphilis tests at the discretion of treating physicians (eg, in case 
of suspicion of active infection) are recorded in the SHCS.
Our primary outcome was incident syphilis episodes (first 
and repeated episodes): We defined repeated syphilis epi-
sodes as a reported positive nontreponemal and treponemal 
test following a syphilis episode and subsequent ≥4-fold titer 
reduction or negativity in nontreponemal testing and a con-
secutive ≥4-fold titer increase with a titer value of at least 8 in 
nontreponemal testing. We defined first syphilis episodes as a 
reported positive nontreponemal and treponemal test in indi-
viduals with a negative first treponemal test within the study 
period. As we could not infer the infection date precisely and 
due to short time intervals between negative and positive syph-
ilis tests, we used the date of positive nontreponemal and trepo-
nemal testing as the infection date estimate.
Data Analysis
To identify risk factors for incident syphilis episodes and 
to account for recurrent events, we fitted univariable and 
multivariable semiparametric Anderson-Gill models—an ex-
tension of the Cox proportional-hazard model, with static and 
time-updated covariables, as described previously [13].
Based on previous reports, an explorative analysis, and clin-
ical opinion, we evaluated the following independent vari-
ables in the univariable and multivariable analysis [10]: year of 
birth, ethnicity (white or nonwhite), education level at baseline 
(with or without continuing education after high school), year 
of HIV infection, and year of syphilis testing; furthermore, we 
evaluated the following time-updated variables, which repre-
sent the individuals’ behavior in the previous 6  months; that 
is, alcohol use (with or without consumption of alcohol more 
than once a month), smoking status (with or without smoking 
of >1 cigarette per day), recreational use of intravenous and/
or nonintravenous drugs (with or without use of recreational 
drugs), CD4 cell count, HIV viral load, ART (on or off ART), 
and sexual risk behavior (MSM with no occasional partners, 
MSM with occasional partners but no condomless anal inter-
course, or MSM with occasional partners having condomless 
anal intercourse). In the final multivariable model, we excluded 
recreational drug use and alcohol consumption, as these vari-
ables were largely missing for the years 2004 to 2007; we in-
cluded both variables in a sensitivity analysis (Supplementary 
Figure 1). In addition, we did not include HIV viral load in the 
final multivariable model due to potential collinearity with CD4 
cell count and ART. Continuous variables were categorized in 
cases of evidence of departure from linearity. We performed an 
additional sensitivity analysis using a marginal-mean model 
(Supplementary Figure 2). We used complete-case analyses in 
all survival models.
In the final multivariable model, the proportional hazards 
assumption was met (Supplementary Figure 3), and respective 
deviance residuals to examine influential observations are re-
ported in Supplementary Figure 4. We performed all analyses 
in R, version 3.5.0 (R Foundation for Statistical Computing, 
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Vienna, Austria). We used the coxph function from the survival 
package in R to fit the Anderson-Gill models and the survminer 
package for model diagnostics.
RESULTS
Within the 14-year observation period, 2513 HIV-infected 
MSM with an initially negative syphilis test formed the study 
population at risk (Figure  1). Of these 2513 individuals, 657 
(26.1%) had at least 1 syphilis episode and 144 (5.7%) had at 
least 2 syphilis episodes; 42 (1.7%) MSM had 3 or more syph-
ilis episodes (Table 1). Overall, MSM with an initially negative 
syphilis test were followed up for 15 002 person-years before 
they were lost to follow-up or had a first syphilis episode; simi-
larly, MSM who had a first syphilis episode were followed up for 
a total of 2184 person-years.
Crude incidence rates of repeated syphilis episodes in MSM 
increased with the number of previous syphilis episodes—ran-
ging from 66 episodes per 1000 person-years in MSM with 1 
previous episode to 538 episodes per 1000 person-years in MSM 
with 6 previous episodes (Table 1). Overall, the median syphilis 
testing rate was 1.30 tests per person-year; we describe time 
trends in syphilis testing in Supplementary Figure 5. Compared 
with MSM with ≤1 prior syphilis episode, individuals with re-
peated syphilis episodes were younger and more frequently had 
an occasional partner and exposure to condomless anal inter-
course with an occasional partner.
The cumulative probability of an incident syphilis epi-
sode increased with the number of previous syphilis episodes 
(Figure 2). In the univariable analysis, the number of prior syph-
ilis episodes (crude hazard ratio [HR] per 1-episode increase, 
1.51; 95% confidence interval [CI], 1.35–1.7), having occasional 
sexual partners with or without condomless anal sex (crude 
HR, 5.59; 95% CI, 4.63–6.74; and crude HR, 2.58; 95% CI, 2.14–
3.12), and being currently on ART (crude HR, 1.62; 95% CI, 
1.22–2.14) depicted the strongest association with subsequent 
incident syphilis episodes (Figure 3). In the multivariable anal-
ysis, the number of prior syphilis episodes (adjusted HR per 
1-episode increase, 1.15; 95% CI, 1.01–1.31), having occasional 
sexual partners with or without condomless anal sex (adjusted 
HR, 4.99; 95% CI, 4.08–6.11; and adjusted HR, 2.54; 95% CI, 
2.10–3.07), and being currently on ART (adjusted HR, 1.62; 
MSM in the SHCS, n = 7947
1253 excluded
2824 excluded
1145 excluded
212 excluded
MSM with at least 1 syphilis test, n = 6694
MSM with first syphilis test after 1st January
2004, n = 3870
MSM with a negative baseline syphilis test,
n = 2725
Included in the final analysis:
MSM with at least 2 syphilis tests, n = 2513
Figure 1. Study population. Abbreviations: MSM, men who have sex with men; SHCS, Swiss HIV Cohort Study.
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95% CI, 1.21–2.16) remained associated with the occurrence 
of incident syphilis episodes. These findings were robust in the 
sensitivity analyses (Supplementary Figures 1 and 2).
DISCUSSION
In the SHCS, we observed a high rate of syphilis among HIV-
infected MSM with previous syphilis episodes, which may 
be explained largely by the sexual risk behavior and the high 
background risk of syphilis among MSM populations [2, 12]. 
We identified several risk factors for the occurrence of syph-
ilis episodes in MSM, which are in line with previous studies 
investigating risk factors for first incident syphilis episodes 
among HIV-infected individuals and specifically among HIV-
infected MSM [2, 14]. However, insufficient adjustment for 
changing sexual risk behavior might have led to residual con-
founding in some studies, and repeated syphilis episodes were 
often not modeled longitudinally [14, 15].
Previous studies have reported that repeated syphilis epi-
sodes may be less symptomatic and that the plasma cytokine and 
VDRL/RPR titer responses differ between individuals with initial 
and repeated syphilis episodes [16, 17]. Other studies found no 
difference in the clinical presentation of patients with initial and 
repeated syphilis episodes [15, 18, 19]. Interestingly, we observed 
no evidence of a decreased syphilis risk among HIV-infected 
MSM with repeated syphilis episodes; however, we cannot ex-
amine with the present study whether a partial attenuation, that 
is, less symptomatic repeated syphilis episodes, could be possible: 
Detailed clinical information on respective symptoms and signs 
was not collected in the SHCS database. In the present study, per 
1-unit increase in the number of previous syphilis episodes, there 
was some evidence of a marginal positive association with the 
occurrence of subsequent syphilis episodes. The respective 95% 
CI of the adjusted HR ranged from 1.01 to 1.31. In the sensitivity 
analysis, the corresponding 95% CI of the adjusted effect esti-
mate ranged from 0.99 to 1.34, with little (nonsignificant) evi-
dence of an association between the number of syphilis episodes 
and the occurrence of subsequent syphilis episodes (Figure  3; 
Supplementary Figure 2). However, these 2 point estimates are 
largely consistent, as the respective effect sizes for previous syph-
ilis episodes are comparable. Nevertheless, a causal, positive asso-
ciation between the number of preceding syphilis episodes and 
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Figure 2. Repeated syphilis episodes in HIV-infected men who have sex with men; Kaplan-Meier estimates. Time is depicted since the previous syphilis episode, or since 
inclusion in the study in cases of absent previous syphilis episode.
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the risk for consecutive syphilis episodes is unlikely but neces-
sitates further immunological investigation. The small potential 
effect of previous syphilis episodes may be explained by residual 
and/or unmeasured confounding effects in high-risk individuals 
(eg, frequency of unprotected anal sex, number of occasional 
partners), which are not collected in the SHCS. Still, our finding 
is in accordance with a previous study performed among MSM in 
HIV care in Ontario, Canada, which reported a 3-fold increased 
rate of syphilis in individuals with a past syphilis diagnosis [20]. 
In line with this study, our cohort was restricted to HIV-infected 
MSM in order to account for potential confounding effects of 
seroadaptive or serosorting behavior (ie, choosing sex partners 
based on HIV status), which may facilitate syphilis transmission 
among MSM [21].
In our individual-level analysis, the observation period was 
too short to examine potential long-term cycles in syphilis in-
cidence. It has been speculated that repeated syphilis episodes 
induce or boost a host immune reaction, which may ultimately 
decrease the propensity of acquiring further syphilis episodes 
and which may have an impact of syphilis transmission dy-
namics at the population level [4, 16]. In contrast to gonorrhea, 
Grassly et al. showed in an ecological modeling study that syph-
ilis epidemics may represent a rare example of endogenous os-
cillation in syphilis incidence with an 8–11-year period that is 
predicted by the natural dynamics of syphilis infection and the 
associated partially protective immunity [6]. However, the hy-
pothesis of endogenous cycling has been questioned [22].
In HIV-infected individuals, preliminary results from cohort 
studies, mathematical models, and reports have suggested that 
ART may be associated with increasing syphilis incidence due to 
changing sexual behavior and a multitude of effects of ART on 
the innate and adaptive immune system [7, 23–25]: The findings 
of the present cohort study, in which we modeled repeated syph-
ilis episodes, are consistent with these investigations and reports; 
however, it is still uncertain whether the ART–syphilis relationship 
is causal, due to potential residual and unmeasured confounding 
(especially for sexual risk behavior such as the frequency of sexual 
intercourse with occasional partners [24, 25]) and the likely effect 
of HIV and ART on false-positive RPR serologies [26].
Our study has limitations. First, our syphilis episode defin-
itions are based on results of nontreponemal and treponemal 
syphilis tests, as repeated syphilis episodes are often asympto-
matic and as data on syphilis symptoms/signs and treatments 
have not been collected systematically in the SHCS database. 
Second, some individuals may not have been counted as having 
a repeated syphilis episode (ie, false negatives) due to a serofast 
state (ie, nontreponemal titers neither increase nor decrease 
4-fold) after treatment of a prior syphilis episode [27]. This may 
Variables Baseline
Nonwhites
Lower than higher education
Less than 1 cigarette
 per day
More than 1 cigarette per day
a) Having occasional partners
but not condomless anal intercourse
b) Having condomless anal
intercourse with occasional partner
On ART
0.50 1.0 2.0
Hazard ratio
4.0 8.0
No occasional partners
O­ ART
Higher than higher education
Whites
Subcategories
Andersen-Gill Model
Number of prior syphilis episodesa
Year of birth
Age at HIV infection
Ethnicity
Education
Year of syphilis testinga
Square root of CD4 cell counta
Smoking statusa
Sexual riska
Anti–retroviral therapy (ART)a
Univariable
Multivariable HR (95% CI)
1.51 (1.35–1.7)
1.15 (1.01–1.31)
1.02 (1.01–1.03)
1.03 (1.01–1.05)
0.99 (0.98–1)
1.02 (0.99–1.04)
0.85 (0.67–1.06)
0.88 (0.7–1.11)
1.12 (0.97–1.3)
1.09 (0.94–1.26)
1.08 (1 .05–1.11)
1.01 (0.97–1.05)
1 (0.99–1.01)
0.98 (0.97–1)
0.92 (0.8–1.07)
0.93 (0.8–1.08)
2.58 (2.14–3.12)
2.54 (2.1–3.07)
5.59 (4.63–6.74)
4.99 (4.08–6.11)
1.62 (1 .22–2.14)
1.62 (1 .21–2.16)
Figure 3. Risk factors for repeated syphilis episodes in HIV-infected men who have sex with men; Andersen-Gill model estimates. All effect estimates are expressed per 
1-unit increase if no categories are stated. aTime-updated variables. Abbreviations: ART, antiretroviral therapy; CD4, cluster of differentiation 4; CI, confidence interval; HR, 
hazard ratio.
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have led to an underestimation of the true incidence of repeated 
syphilis episodes and may have negatively confounded the asso-
ciation between previous syphilis episodes and subsequent inci-
dent syphilis infections; thus, the observed positive association 
between previous syphilis and subsequent syphilis episodes may 
be stronger. Third, we cannot exclude the possibility of residual 
and unmeasured confounding; for instance, the frequency of 
sexual intercourse and the number of occasional sexual partners 
are not collected in the SHCS database. Fourth, our study find-
ings may not be generalizable to other populations with different 
risk profiles and immunological responses to syphilis [28].
However, our study has major strengths. First, our analyses 
were based on a large prospective cohort study with standard-
ized, routine syphilis testing. Second, we analyzed risk factors 
for incident syphilis episodes in a well-defined population over 
a very long observation period—with a high retention pro-
portion among participants. Third, our statistical models ac-
counted for recurrent events and changes in risk behavior over 
time; this allowed us to longitudinally estimate the impact of 
repeated syphilis episodes on consecutive syphilis risk.
CONCLUSIONS
In HIV-infected MSM, we observed no indication of decreased 
syphilis risk with repeated syphilis episodes. The extent of 
sexual risk behavior over time was the strongest risk factor for 
recurrent syphilis episodes. The observed association of ART 
with repeated syphilis episodes may not be causal and warrants 
further epidemiological and immunological investigation.
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